Molecular Marker Discovery and Evaluation: EGF rs1897990 and rs1524106 Variants in a China Lung Adenocarcinoma Young Population
The Clinical Respiratory Journal · 2025
DOI: 10.1111/crj.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2025. Verfasst von Huiwen Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Polymorphism, Single Nucleotide, Epidermal Growth Factor, Lung Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu University Clinical Medicine Science and Technology Development Fund, Zhenjiang First People's Hospital Research Fund.
Abstract (Originalsprache)
Objective
The objective of this study is to investigate the genetic susceptibility and risk factors of EGF gene rs1897990 and rs1524106 in lung adenocarcinoma young patients aged ≤ 45 years.
Methods
A case–control study was conducted. DNA was extracted and identified from 88 samples from case and control groups by single‐nucleotide polymorphism assay. PCR amplification was performed by TaqMan probe method, and the factors of smoking, drinking, sex, and age were also included. To investigate the clinical factors and genotyping differences between case and control groups.
Results
Smoking was an influential factor in young lung adenocarcinoma patients. The mutation frequency of EGF gene rs1897990 CT heterozygous mutant was different between the two groups ( p = 0.021). The T alleles of EGF rs1897990 and rs1524106 were significantly different between the two groups ( p = 0.034 and p = 0.023).
Conclusions
The young lung adenocarcinoma population (≤ 45 years old) is susceptible to EGF rs1897990 and rs1524106 variants, with smoking being another risk factor. Additionally, smoking may enhance the risk of EGF rs1897990 and rs1524106 variants threatening the development of lung adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
- Troop 73071 of the PLA, Xuzhou, Jiangsu, China.
- Department of Otolaryngology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
ORCID-Profile: Huiwen Pan, Jinye Wang
Förderung
- Jiangsu University Clinical Medicine Science and Technology Development Fund
- Zhenjiang First People's Hospital Research Fund
Zitieren
APA
Pan, H., Wang, X., Zheng, L., Wang, J., Ding, G., Zhu, J., & Fang, Z. (2025). Molecular Marker Discovery and Evaluation: EGF rs1897990 and rs1524106 Variants in a China Lung Adenocarcinoma Young Population. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70113
Vancouver
Pan H, Wang X, Zheng L, Wang J, Ding G, Zhu J, et al. Molecular Marker Discovery and Evaluation: EGF rs1897990 and rs1524106 Variants in a China Lung Adenocarcinoma Young Population. The Clinical Respiratory Journal. 2025. doi:10.1111/crj.70113
BibTeX
@article{Pan2025,
author = {Pan, Huiwen and Wang, Xiangyang and Zheng, Lijie and Wang, Jinye and Ding, Guowen and Zhu, Jingfeng and Fang, Zhijie},
title = {Molecular Marker Discovery and Evaluation: EGF rs1897990 and rs1524106 Variants in a China Lung Adenocarcinoma Young Population},
journal = {The Clinical Respiratory Journal},
year = {2025},
doi = {10.1111/crj.70113}
}
EUVIMED